Literature DB >> 1922173

Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes.

D J Lange1, M Rubin, P E Greene, U J Kang, C B Moskowitz, M F Brin, R E Lovelace, S Fahn.   

Abstract

We used single fiber electromyography (SFEMG) to study 42 patients who had enrolled in a double-blind, placebo-controlled trial undertaken to assess the efficacy of botulinum toxin (BTX) injection of neck muscles to treat torticollis. SFEMG in a limb muscle was performed before treatment, 2, and 12 weeks after injection of placebo or BTX. Before treatment, the mean jitter was 26.8 microsec in patients who were to receive BTX, and 25.7 microsec in the placebo group. Two weeks after injection, mean jitter in the group receiving BTX was 43.6 microsec. In the placebo group, it was 26.5 microsec (P = less than .05). Twelve weeks after injection, mean jitter in the BTX group was 35.5; for the placebo group it was 24.5. Fiber density did not change in any patient during the study. There were no remote clinical effects of BTX. Injection of BTX into muscles affected with focal dystonia is a promising and safe treatment, but there are subclinical effects on uninjected muscles.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922173     DOI: 10.1002/mus.880140711

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  25 in total

Review 1.  Botulinum toxin for the treatment of movement disorders.

Authors:  Mary Ann Thenganatt; Stanley Fahn
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

2.  Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.

Authors:  Takeshi Iwase; Chie Iwase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-21       Impact factor: 3.117

3.  Botulinum toxin A during pregnancy: a survey of treating physicians.

Authors:  J C Morgan; S S Iyer; E T Moser; C Singer; K D Sethi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 4.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

5.  Successful treatment of intractable tardive dyskinesia with botulinum toxin.

Authors:  J Yasufuku-Takano; M Sakurai; I Kanazawa; M Nagaoka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

Review 6.  Botulinum toxin type A therapy for cervical dystonia.

Authors:  Mafalda Castelão; Raquel E Marques; Gonçalo S Duarte; Filipe B Rodrigues; Joaquim Ferreira; Cristina Sampaio; Austen P Moore; João Costa
Journal:  Cochrane Database Syst Rev       Date:  2017-12-12

7.  Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A.

Authors:  Saedeh Dadgar; Zack Ramjan; Wely B Floriano
Journal:  J Med Chem       Date:  2013-03-29       Impact factor: 7.446

Review 8.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

Review 9.  Use of botulinum toxin A in adult neurological disorders: efficacy, tolerability and safety.

Authors:  Wilhelm J Schulte-Mattler
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Influence of injection of Chinese botulinum toxin type A on the histomorphology and myosin heavy chain composition of rat gastrocnemius muscles.

Authors:  Bin Hong; Min Chen; Xing-yue Hu
Journal:  J Zhejiang Univ Sci B       Date:  2013-11       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.